Therapeutic Area Strategy Executive Director, Oncology & Hematology
Share
Job Location:
Basel - Switzerland
Monthly Salary:
Not Disclosed
Posted on:
Yesterday
Vacancies:
1 Vacancy
Job Summary
Job Description Summary
Location: Basel Switzerland or Cambridge MA East Hanover NJ US. This role will follow a hybrid working model.If based in the US please apply to REQ-
LI-#hybrid
The Novartis Strategy & Growth Therapeutic Area Strategy team for Oncology is seeking a new Therapeutic Area Strategy Executive Director Oncology & Hematology who will support the creation and update of a holistic TA strategy; provide early-phase commercial insights to project teams; guide TA-specific internal pipeline development and external licensing / acquisitions opportunities; and support integrated enterprise alignment across Biomedical Research (BR) Development Strategy & Growth (S&G) and the Commercial US and International units.
Job Description
Key Responsibilities:
- Brings external benchmarking analysis and insights and judgement to support the TA Strategy Head in developing a holistic Novartis TA strategy that achieves sustainable growth in short mid and long-term.
- Brings both understanding of the pharmaceutical industry and the core Therapeutic Areas (TA) and Disease area of Oncology & Hematology to derive insightful and differentiating competitive advantages over our peers.
- Provides key commercial insights to the R&D project teams particularly for early phase programs. To do this effectively in-market experience in the US is critical.
- Analyses reports and publications to extract key messages including building product forecasts.
- Supports development and delivery of TA-specific strategic external insights to support identification of growth opportunities emerging competitive challenges and support creation of a third-party view around key strategic levers and commissions targeted primary research.
Essential Requirements:
- Bachelors degree required. Advanced degree (PhD MD or other advanced University degree) and / or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly preferred.
- In-depth TA knowledge (or track record to acquire required TA expertise effectively and rapidly) in Oncology and Hematology.
- Highly agile having the capacity to support a number of strategic DAs within a TA and multiple programs internal and external
- Substantial experience evaluating new product opportunities (through M&A BD&L and internal re-search programs).
- At least 7-9 years of Industry pharma and/or medical devices Experience in Research & Development and/or commercial functions with experience conducting commissioning analyzing primary research
- Experience of strategy development and asset shaping early in lifecycle (any functional perspective)
- Recent (post 2015) local US in-market experience; local US experience includes working within the US market with the local US customers US health care systems / systems
Commitment to Diversity and Inclusion:
Novartis is committed to building an outstanding inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and Accommodation:
Novartis is committed to working with and providing reasonable accommodation to all individuals. If because of a medical condition or disability you need a reasonable accommodation for any part of the recruitment process or in order to receive more detailed information about the essential functions of a position please send an e-mail to and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Skills Desired
Business Development Business Strategy Collaboration Curiosity Data Analytics Decision Making Skills Finance Go-To-Market Strategy Influencing Skills Leadership Operations Prioritization Strategic Partnerships Strategic PlanningRequired Experience:
Director
Key Skills
About Company
Novartis is a global healthcare company based in Switzerland that provides solutions to the evolving needs of patients worldwide.
